I.G. Investment Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
QF
AWG
HM
AC
SM
I.G. Investment Management's ABUS Position: Q3 2016 in Review
I.G. Investment Management sold out of Arbutus Biopharma (ABUS) in Q3 2016, closing a stake of 250,000 shares — an estimated $870K sold.
I.G. Investment Management first reported a position in ABUS in Q2 2013 and held it in 7 quarters. The position peaked at $1.38M in Q1 2014. 48 funds tracked by Wall St. Rank hold ABUS as of Q3 2016.
- I.G. Investment Management reported no remaining Arbutus Biopharma position as of Q3 2016 after selling out during the quarter.
- I.G. Investment Management sold 250,000 Arbutus Biopharma shares in Q3 2016, an estimated $870K.
- I.G. Investment Management first reported a position in Arbutus Biopharma in Q2 2013 and held it in 7 quarters.
- I.G. Investment Management's Arbutus Biopharma position peaked at $1.38M in Q1 2014.
- 48 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2016.
Based on I.G. Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.